| Net Cash Provided by (Used in) Operating Activities |
$272,000 |
USD |
-29% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$849,000 |
USD |
5206% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
7,677,471 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$1,121,000 |
USD |
182% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$5,222,000 |
USD |
-32% |
Q3 2025 |
Q3 2025 |
| Property, Plant and Equipment, Gross |
$28,577,000 |
USD |
5.7% |
Q3 2025 |
Q3 2025 |
| Deferred Income Tax Expense (Benefit) |
$240,000 |
USD |
-53% |
Q3 2025 |
Q3 2025 |
| Deferred Federal Income Tax Expense (Benefit) |
$62,000 |
USD |
-49% |
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$943,000 |
USD |
0% |
Q3 2025 |
Q3 2025 |
| Current Federal Tax Expense (Benefit) |
$62,000 |
USD |
-56% |
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
$540,000 |
USD |
81% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$385,000 |
USD |
26% |
Q4 2024 |
FY 2024 |